
Number of publications published per year by Livingston, Stephen. (Source : PubMed)

Distribution of publications types for Livingston, Stephen. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)



Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.
Gastroenterology
2010;138;3

Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.
J. Virol.
2009;83;18

Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.
Cancer Epidemiol. Biomarkers Prev.
2009;18;1
Innovations in surgical oncology at Baylor University Medical Center.
Proc (Bayl Univ Med Cent)
2008;21;1


Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
J. Viral Hepat.
2006;13;10


Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
Liver Int.
2006;26;6
Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utility.
Cancer Control
2006;13;1

Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.
Clin. Cancer Res.
2006;12;1

Epidemiology and risk factors for hepatitis C in Alaska Natives.
Hepatology
2004;39;2
A randomized trial of valved vs nonvalved implantable ports for vascular access.
Proc (Bayl Univ Med Cent)
2003;16;4
[ See timeline ] [ See all publications ]
means that Livingston, Stephen has 11 papers cited a least 11 times - methodology
H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.